Resting-state magnetoencephalography as a biomarker for cognitive decline in MS


  • Resting-state magnetoencephalography (MEG) measurements are clinically comparable with electroencephalography and are a reliable biomarker for cognitive function in people with multiple sclerosis (MS).

Why this matters

  • A reliable biomarker for cognitive functioning in people with MS would enhance the ability to objectively evaluate cognitive decline.